We spent a wonderful couple of days in Tours, France, discussing innovative solutions for designing therapeutic antibodies at the International Workshop on Autologous DNA-Based Antibody Production.
Our CEO, Luigi Aurisicchio, and our CSO, Giuseppe Roscilli, participated in a synergistic working group aimed at exploring innovative genetic designs, intelligent solutions, and new manufacturing concepts for application in both human and veterinary medicine.
Nucleic acid-based methods for delivering antibody gene sequences, enabling in situ production, have garnered significant attention due to their cost-effectiveness and rapid scalability.
There is growing indication that self-produced therapeutic antibodies could represent a groundbreaking frontier in treating chronic diseases, infections, and cancer.
We thank Le Studium for bringing together such a talented and diverse group of researchers in this workshop, as part of the ARD CVL biopharmaceutical program, led by the University of Tours.
We thoroughly enjoyed engaging in discussions about the opportunities and challenges of this innovative platform and look forward to future collaborations to collectively design new solutions!
#pharma #pharmaceutical #biotech #biotechnology #research #antibodies
